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Abstract
Background: Cancer stem cells are suggested to contribute to the extremely poor prognosis of pancreatic ductal
adenocarcinoma and dysregulation of symmetric and asymmetric stem cell division may be involved. Anticancer
benefits of phytochemicals like the polyphenol quercetin, present in many fruits, nuts and vegetables, could be
expedited by microRNAs, which orchestrate cell-fate decisions and tissue homeostasis. The mechanisms regulating
the division mode of cancer stem cells in relation to phytochemical-induced microRNAs are poorly understood.
Methods: Patient-derived pancreas tissue and 3 established pancreatic cancer cell lines were examined by
immunofluorescence and time-lapse microscopy, microRNA microarray analysis, bioinformatics and computational
analysis, qRT-PCR, Western blot analysis, self-renewal and differentiation assays.
Results: We show that symmetric and asymmetric division occurred in patient tissues and in vitro, whereas
symmetric divisions were more extensive. By microarray analysis, bioinformatics prediction and qRT-PCR, we
identified and validated quercetin-induced microRNAs involved in Notch signaling/cell-fate determination. Further
computational analysis distinguished miR-200b-3p as strong candidate for cell-fate determinant. Mechanistically,
miR-200b-3p switched symmetric to asymmetric cell division by reversing the Notch/Numb ratio, inhibition of the
self-renewal and activation of the potential to differentiate to adipocytes, osteocytes and chondrocytes. Low miR-
200b-3p levels fostered Notch signaling and promoted daughter cells to become symmetric while high miR-200b-
3p levels lessened Notch signaling and promoted daughter cells to become asymmetric.
Conclusions: Our findings provide a better understanding of the cross talk between phytochemicals, microRNAs
and Notch signaling in the regulation of self-renewing cancer stem cell divisions.
Background
Pancreatic Ductal Adenocarcinoma (PDA) is a highly
malignant tumor with late diagnosis and poor progno-
sis [1]. The tumors are believed to proliferate rapidly,
re-occur, be resistant or result in metastasis with cancer
stem cells (CSCs) as main responsive mediator [2].
CSCs may be potential diagnostic and therapeutic tar-
gets because of their roles in carcinogenesis [3]. CSCs
are known for their self-renewing and/or differentiation
potential [4]. CSC self-renewing division gives rise to
symmetric or asymmetric cell division. The former,
resulting to two identical daughter cells and the later to
two dissimilar daughter cells [5]. Asymmetric division
is performed by CSCs for homeostasis [6] while sym-
metric division results in exponential tumor growth [7].
Studies have shown different regulators of the CSCs
mode of divisions [8]. Notable amongst them is the
Notch signaling pathway [9–11]. It is a highly dysregu-
lated pathway in cancer [12]. Notch is an essential gene
encoding a signaling receptor, which has a major con-
tribution to proper development, cell fate decision, cell
proliferation and survival [13, 14]. Notch is suggested
as marker for symmetric cell division and oncogene
[10, 15, 16]. Notch inhibitor [17], Numb, is a cell fate
determinant [18] and implicated as a tumor suppressor
[19] and marker for asymmetric cell division [20].
Via the modulation of the Notch signaling pathway,
microRNAs (miRs) have been identified to play a major
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role in CSCs fate determination [21, 22]. MiRs are small
non-coding RNAs that functions in RNA silencing and
post transcriptional regulation of gene expression [23].
MiR therapy therefore offers an attractive anti-tumor ap-
proach. Recently, we have shown that the anti-cancer
phytochemical, quercetin, regulates the expression of
miRs in PDA via Notch signaling [24].
Quercetin is a flavonoid obtained from plant sources
such as leafy vegetables, onions, apples, black tea and
nuts [25]. However, irrespective of the importance of
quercetin modulation of miR signaling in PDA and
miR-mediated role in CSCs fate determination via the
Notch signaling pathway, it remains unknown whether
an individual quercetin-induced miR plays any role in
the regulation of the mode of self-renewing divisions
in PDA.
Here, we show that, both symmetric and asymmetric
modes of division occur in PDA with symmetric div-
ision mostly occurring, especially at the principal sites
of three proliferation and asymmetric division at the
periphery. This phenomena results to exponential pro-
liferation, increase in the levels of Notch and decrease
in Numb levels. Using miR profiling, we show that
miR-200b-3p is upregulated after quercetin treatment
of PDA cells. In silico analyses suggests miR-200b-3p
as a cell fate determinant miR in PDA as it is pre-
dicted to target the segregating determinants in hu-
man. MiR-200b-3p is shown to switch the mode of
CSCs division from symmetric to asymmetric division
by inhibiting Notch and activating Numb. This obser-
vation is further reinforced by time-lapse microscopy
analysis. Investigation of CSCs self-renewal in vitro,
demonstrated a vital role for miR-200b-3p to inhibit
CSCs self-renewal and subsequently, induce osteo-
genic, adipogenic and chondrogenic differentiations.
These studies offer new insights into the mode of self-
renewing CSCs divisions, underscoring the distinctive
regulatory functions accomplished by miRs.
Methods
Tumor cell lines
Pancreatic cancer established cell lines; AsPC1 and
PANC1 were obtained from the American Type
Culture Collection (Manassas, VA, USA) and recently
authenticated by a commercial service (Multiplexion,
Heidelberg, Germany). The human, primary pancreatic
cancer cell line ASANPaCa was generously provided by
Dr. Nathalia Giese and is described [26]. Frozen stocks
were prepared from initial stocks, and every 3 months a
new frozen stock was used for experiments in order to
maintain the authenticity of the cell lines. Monthly
examination ensured mycoplasma negative cultures.
Cells were cultured in DMEM (PAA, Pasching, Austria)
supplemented with 10% heat-inactivated FCS (Sigma,
Deisenhoffen, Germany) and 25 mmol/L HEPES (PAA,
Pasching, Austria).
Cell synchronization
All cells were synchronized prior to any experiment by
serum starvation as previously described [27, 28]. The
cells were seeded with 10% FCS culture medium on the
first day. On the second day, the medium was removed
and the cells synchronized with 0.1% FCS culture
medium for 24 h.
Tumorsphere forming assay and analysis
PDA cells were resuspended in tumorsphere DMEM/
F12 medium (Thermo Fisher Scientific Inc., Dreieich,
Germany) supplemented with B27 supplement (50×)
(Thermo Fisher), 20 ng/mL rEGF (Thermo Fisher),
20 ng/mL bFGF (Thermo Fisher), 5 μg/mL I nsulin
(Sigma, Deisenhoffen, Germany) and 5 mL Glutamax
(Thermo Fisher). To avoid false positives as a result of
cell aggregation, 1000 cells in 50 μL tumorsphere
medium mixed with 50 μL matrigel were cultured per
well of a 24-well plate. The mixture was allowed to
polymerize for 1 h at 37 °C and 5% CO2. Subsequently,
1 mL of the tumorsphere medium was added per well,
either alone or supplemented with 50 nM mirVana™
mimics or 50 μM quercetin. Seventy-two hours later,
the spheres were collected by gentle centrifugation,
dissociated into single cells, and cultured for the for-
mation of next generation spheres. Tumor spheres
were counted using an inverted microscope (Nikon
Eclipse TS100; Nikon GmbH, Düsseldorf, Germany).
To quantify cell numbers, the tumor spheres were col-
lected and disassociated with Trypsin-EDTA (Thermo
Fisher) to make a single cell suspension. The viable
cells were then counted using the Z™ Series COULTER
COUNTER® Cell and Particle Counter (Beckman
Coulter, Indianapolis, USA).
Time-lapse microscopy
Cells were plated at low density in μ-Dish 35 mm (Ibidi,
Germany) and placed in the Nikon BioStation IM-Q
(Nikon Instruments Europe) compact cell incubator
and monitoring system. Cells were photographed every
30 min for about 80 h. The microscope was equipped
with an incubator that maintains the temperature at
37 °C, a humidifier that maintains a humidity level of
95% and a stable CO2 flow of 5%. Time-lapse sequences
were combined using FIJI software.
Evaluation of differentiation to adipocytes
Cells were seeded at a density of 4.5 × 104 cells/well in
6-well cell culture plates. At about 90% cell density, cells
were left untransfected, treated with 50 μM quercetin or
were transfected with 50 nM mirVana™ mimics of miR-
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200b-3p or a miR-NC (Thermo Fischer Scientific,
Waltham, MA USA) using lipofectamine RNAiMax re-
agent (Life Technologies, Darmstadt, Germany) for every
72 h for a period of 12 days. The cells were washed
with PBS, fixed with methanol for 5 min at room
temperature and incubated with Oil Red O staining
reagent for 20–30 min on a plate shaker at room
temperature. Afterwards, the cells were washed with
deionized water. Heterogeneous adipocytes are stained
red by the Oil Red O staining solution and visualized
with a 10× magnification using an inverted microscope
(Nikon Eclipse TS100; Nikon GmbH, Düsseldorf,
Germany).
Evaluation of differentiation to osteoblasts
Cells were seeded and treated as described above. The
cells were washed with PBS, fixed with 10% neutral buff-
ered formalin for 60 s and incubated in the dark with
FAST BCIP/NBT (Sigma) for 10–20 min. Afterwards,
cells were washed with deionized water. Heterogeneous
alkaline phosphatase expressed by osteoblasts develops
the NBT substrate into deep bluish purple color.
Evaluation of differentiation to chondrocytes
Cells were seeded and treated as described above. The
cells were washed with PBS and fixed with 10% neutral
buffered formalin for 60 min at room temperature. After
two rounds of washing with distilled water, the cells were
incubated overnight in the dark at room temperature with
Alcian blue staining solution (Sigma-Aldrich, St. Louis,
Missouri, USA). Heterogeneous chondrogenic differenti-
ation was identified as intense dark-blue coloration due to
the formation of aggrecan.
Western blot analyses
Western blot analyses were done as formerly described
[29]. Antibodies used include: rabbit antibodies against
human Notch (Cell Signaling Technology, Danvers,
USA), Numb (Cell Signaling Technology, Danvers, USA)
(Cell Signaling Technology, Danvers, USA), and β-actin
(Sigma-Aldrich, St. Louis, Missouri, USA).
Patient tissue
Patient materials were obtained under the approval of
the ethical committee of the University of Heidelberg
after receiving written informed consent from the pa-
tients. The diagnoses were established by conventional
clinical and histological criteria according to the World
Health Organization (WHO). All surgical resections
were indicated by the principles and practice of onco-
logical therapy.
Immunohistochemical and Immunofluorescence staining
Staining was done on 6-μm frozen tissue sections or in
established cell lines as previously described [29, 30].
MicroRNA transfection
MirVana™ mimics (miR-200b-3p and miR-NC) (Thermo
Fisher Scientific Inc., Dreieich, Germany), 50 nM each,
were transfected into the cells using Lipofectamine 2000
(Thermo Fisher) or Lipofectamine RNAiMAX transfec-
tion reagent (Thermo Fisher) with the reverse transfection
method as described in the manufacturer’s instructions.
Dual-Luciferase® reporter assay
Cells were seeded at a density of 1 × 104 cells per well
of a 96-well plate and co-transfected with 50 nM miR
mimics, 25 ng/well of firefly luciferase plasmid and
50 ng/well renilla luciferase reporter construct expressing
Notch1 3‘UTR (BioCat, Heidelberg, Germany). The cells
were lysed in Passive Lysis Buffer of the Dual Luciferase®
Assay System (Promega, Mannheim, Germany) at 48 h
post-transfection. Renilla and firefly luciferase (Promega)
activities were measured on the FLUOstar OPTIMA
instrument (BMG Labtech, Ortenberg, Germany).
MicroRNA Microarray profiling and analyses
This was performed using the Agilent Human miRNA
Microarray (Release 19.0) as previously described [24].
MicroRNA in silico analyses
The miRNA gene targets’ predictions based on miRanda
and TargetScan and PicTar were downloaded from
http://www.microrna.org [31], http://www.targetscan.org
[32] respectively. “Good” mirSVR score refers to miRNA
targets with < −0.1 score, and “non-good” mirSVR score
refers to targets with > −0.1 score obtained from the sup-
port vector regression algorithm mirSVR, available with
miRanda predictions from http://www.microrna.org.
Taqman miRNA RT-qPCR
This was done as previously described [24]. cDNA was
prepared from 500 ng total RNA using the Taqman®
Reverse Transcription Reagents (Thermo Fisher Scientific,
Dreieich, Germany) in accordance to the manufacturers’
instructions. Quantitative levels of hsa-miR-200b-3p were
measured from 1 μl of synthesized cDNA using their re-
spective primer assays and RNU44 as endogenous control
(Applied Biosystems, Darmstadt, Germany). Notch1 and
Numbl mRNA levels were quantified from 2 μl of synthe-
sized cDNA using the TaqMan Gene Expression Assay
and primers for Notch1, Numbl and GAPDH (Thermo
Fisher Scientific). StepOne Real-Time PCR System
(Applied Biosystems) was used for the PCR. Changes in
the relative concentration were calculated with the second
derivative maximum method 2−ΔCT. ΔCT was calculated
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by subtracting the CT of the housekeeping gene from the
CT of the gene of interest. The fold change was obtained
by the equation 2−ΔΔCT.
Statistical analyses
The quantitative data are presented as the mean ± SD.
The data were analyzed using Student’s t-test for statis-
tical significance. P < 0.05 was deemed to be statistically
significant.
Results
Symmetric Cell Division (SCD) mostly occurs in PDA cells
It is an established fact that CSCs divide by both sym-
metric and asymmetric cell divisions [5] with asymmet-
ric division maintaining suitable numbers of cell
offspring [6] and symmetric division, imperative for
growth and regenerative competences [7]. In addition,
Notch and Numb genes are crucial to self-renewing di-
visions as markers for symmetric and asymmetric div-
ision markers respectively [5] (Fig. 1a). Hence, we set
out to identify the mode of CSCs divisions occurring in
PDA. To this end, firstly, we performed immunofluor-
escence analysis using PDA patient samples, staining
for Notch and Numb. The expression of Notch was ob-
served to be more than Numb. Notch expressions were
found mostly at the pancreatic ductal glands, while
Numb was mostly expressed at the periphery (Fig. 1b).
This observation was verified by double immunofluores-
cence staining of the ductal marker, cytokeratin with
notch; cytokeratin with numb and the human proliferation
marker, Ki67 with Notch (Additional file 1: Figure S1).
Secondly, we performed time-lapse microscopy, monitor-
ing synchronized single PDA cells from the established
and CSC-enriched cell lines AsPC1 and PANC1 [33] for a
period of 3 consecutive divisions. Studies show that a cell
divides symmetrically, if its first three divisions results to
2, 4 and 8 cells respectively, and asymmetrically if it is 2, 3
and 5 cells instead [7, 34] (Fig. 1c). Our results show that
the cells were mostly undergoing symmetric division
(Fig. 1d, Additional file 2: Movie S1). The monitored
AsPC1 cells had 70% symmetric, 25% asymmetric and 5%
ambiguous (Data not shown). The monitored PANC1 cells
had 80% symmetric, 10% asymmetric and 10% ambiguous
(Data not shown). These observations suggest that both
symmetric and asymmetric cell division transpire in PDA
with symmetric division being more widespread.
Quercetin upregulates miR-200b-3p
To study a putative effect of quercetin, known to target
pancreatic CSCs [35, 36], miR signaling and the mode of
CSCs divisions, we performed a miR expression profiling
of synchronized AsPC1 cells before and after treatment
with quercetin for 12 h. The microarray data with the
accession number E-MTAB-4718, was uploaded to Array
Express and 105 miRs were found to be differentially
expressed. Of these, 80 miRs were upregulated and 25
miRs were down-regulated (Fig. 2a). On the grounds
that Notch signaling is implicated in CSCs’ fate deter-
mination, we performed in silico analyses, with interest
to only the miRs out of the 105 differentially regulated
that are involved in Notch signaling. This resulted to
only 11 miRs namely; let-7c, miR-200a-3p, miR-200b-3p,
miR-103a-3p, miR-1202, miR-125b-5p, miR-1268a, miR-
6088, miR-3665, miR-4651 and miR-96-5p (Fig. 2a). The
microarray data was validated by qRT-PCR analysis
using six out of the 11 miRs (Fig. 2b).
Fig. 1 PDA cells mostly divide symmetrically. a Schematic
illustration of symmetric cell division (SCD) and asymmetric cell
division (ACD) in low and high-grade tumorigenesis. b Frozen,
human PDA tissue sections were stained for Notch (green), Numb (red)
and counterstained with Dapi (blue). The Notch and Numb images
were merged using FIJI software. The white arrows mark positive
Notch staining on the proliferative sites. c Schematic illustration of SCD
and ACD by time-lapse microscopy. d Established PDA cell lines were
monitored by time-lapse microscopy under physiologic conditions for
a period of 3 divisions and a total of 80 h. The number of visible cells is
indicated on each slide
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MiR-200b-3p as a cell fate determinant
To select the most important candidate miR from the
11, we performed a further in silico studies using the
TargetScan® database to evaluate which of these miRs
was predicted to target Notch and the human segregat-
ing determinants; Numb, Prox1 and Trim (Fig. 2c). MiR-
200b-3p was identified as the only candidate (Fig. 2d,
Additional file 3: Data 1), thus suggesting that this miR
could be a cell fate determinant in PDA.
MiR-200b-3p directly targets the Notch1 3’UTR
Considering that the segregating determinants, Numb,
Prox1 and Trim directly or indirectly inhibits Notch, we
opted to validate Notch1 as a direct target of miR-200b-
3p. Whence, we performed a dual luciferase reporter assay
using a commercially available renilla luciferase reporter
construct expressing the Notch1 3’UTR. AsPC-1, Asan-
PaCa and PANC-1 cells were co-transfected with a re-
porter construct of the Notch1 3’ UTR or with control
firefly plasmid together with either miR-200b-3p mimic or
a miR non-coding control (miR-NC). Forty-eight hours
after transfection, the luciferase activity was quantified in
a luminescence microplate reader. We found a signifi-
cantly reduced luciferase activity of the Notch1 reporter in
the presence of miR-200b-3p, whereas no reduction of lu-
ciferase activity occurred with the empty vector control or
in the presence of miR-NC (Fig. 3a). These results fitly
show that Notch1 is a direct target gene for miR-200b-3p.
MiR-200b-3p switches symmetric to asymmetric division
To establish the correlation between the observed down-
regulation of miR-200b-3p and upregulation of Notch1 in
control PDA cells, we quantified the mRNA and protein
expressions of Notch1 and Numb. Our results show
upregulation of Notch1 and down-regulation of Numb
in control groups but a complete reversal of this
phenomenon in miR-200b-3p and quercetin treated
groups (Fig. 3b, c), indicating a possible switch from
symmetric to asymmetric division. To validate this
assumption, we performed a time-lapse microscopy,
monitoring synchronized miR-NC and miR-200b-3p
transfected AsPC1 cells for 3 division phases over 80 h.
We observed that 75% of the control cells divided sym-
metrically, 20% asymmetrically and 5% ambiguously,
while 60% of the miR-200b-3p-transfected cells divided
asymmetrically, 30% symmetrically and 10% ambiguously
(Fig. 3d). In toto, these results imply that miR-200b-3p
switches the mode of CSCs division from symmetric to
asymmetric.
MiR-200b-3p inhibits CSCs self-renewal and proliferation
Next, we questioned if the switch from symmetric to
asymmetric division is associated with CSCs self-renewal
and proliferation. Hypothetically, symmetric division
would result to more self-renewal and proliferation than
ACD by inhibiting Notch signaling (Fig. 4a). Then, we
performed serial tumorsphere propagation assays to
Fig. 2 MiR-200b-3p could be a cell fate determinant miRNA. a In silico analyses was used to identify 11 out of 105 differentially regulated miRs, as
players in Notch signaling/cell fate determination. b Using qRT-PCR, the microarray data was validated by Taqman® miRNA assay. RNA isolation
from untreated (CO) and treated (Q, 50 μM) AsPC1 cells, followed by reverse transcription and PCR. RNU44 was used to normalize the expression
levels and the average fold change of the CO was set to 1, while the expression level in the quercetin-treated cells was related to the control.
c Human homolog of the segregating determinants. d Putative binding sites of miR-200b-3p in the 3’UTR of the segregating determinants
(Numb, Prox1, and Trim2) and Notch1 was identified using TargetScan database. The seed-binding regions are marked in red. All assays were
performed in triplicates, repeated at least three times and the means ± S.D. are shown. *P < 0.05, **P < 0.01
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evaluate the impact of miR-200b-3p on self-renewal and
proliferation. Resuspended cells in tumorsphere medium
were mixed in a ratio of 1:1 with matrigel and plated in a
24-well plate to avoid false positives and ensure that
tumorspheres resulted from single CSCs and not from the
aggregation of cells. Upon polymerization, the mixture
was covered with unadorned tumorsphere medium (CO)
or transfection mixture of the tumorsphere medium with
50nM of miR-NC/miR-200b-3p or 50 μM of quercetin in
the tumorsphere medium. Subsequently, the resultant
tumorspheres were passaged for three generations. MiR-
200b-3p and quercetin significantly decreased tumor-
sphere formation (Fig. 4b). After being passaged for three
generations, the ability to form new tumorspheres was
Fig. 3 MiR-200b-3p switches SCD to ACD. a MiR-200b-3p targeting
the Notch1 mRNA through a targeting sequence located at the
3’UTR. Dual luciferase assay were performed to test the interaction
of miR-200b-3p and its targeting sequence in the Notch1 3’UTR
using constructs containing the predicted targeting sequence
cloned into the 3’UTR of the reporter gene. Data represent three
independent experiments with triplicate measurements. b AsPC1,
AsanPaCa and PANC1 cells were transfected with 50 nM miR-200b-
3p or miR-NC mimics or were treated with 50 μM quercetin (Q) or
not (CO). Forty-eight-hours after transfection, the cells were utilized
for Taqman® gene expression assays, quantifying Notch1 and Numb
expressions. GAPDH served as control for equal conditions. c AsPC1
cells were treated as described above and total proteins obtained
and analyzed by western blot. β-Actin served as controls for equal
conditions. d AsPC1 cells transfected with 50 nM miR-200b-3p or
miR-NC mimics were monitored by time-lapse microscopy under
physiologic conditions for a period of 3 divisions. All assays were
performed in triplicates, repeated at least three times and the mean
± S.D. are shown. *P < 0.05, **P < 0.01 Fig. 4 MiR-200b-3p inhibits CSCs self-renewal in vitro. a Schematic
illustration of SCD and ACD with respect to self-renewal. Notch
signaling and self-renewal are active in the both daughter cells in
SCD. In ACD, notch signaling is activated in one and the other is
inactive. b AsPC1, AsanPaCa and PANC1 cells in 1:1 mixture of
tumorsphere medium and matrigel were seeded in a 24-well plate
and allowed to polymerize. One milliliter of plain tumorsphere
medium without treatment or 50 nM miR-NC transfection mixture
or 50 nM miR-200b-2p transfection mixture or 50 μM quercetin was
added to the CO, miR-NC, miR-200b-3p and Q groups respectively. The
resulting tumorspheres were passaged for 3 generations
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practically lost in cells from the miR-200b-3p and quer-
cetin treated groups whereas cells from the control groups
(CO and miR-NC) significantly continued to form tumor-
spheres (Figs. 4b and 5a). These observations are in coher-
ence with the switch from symmetric to asymmetric
division by miR-200b-3p. Next, we evaluated the influence
on proliferation by dissociating the tumorspheres from
each group to single cells using trypsin-EDTA. The viable
cells were then counted using the automated Z™ Series
COULTER COUNTER® Cell and Particle Counter. Like-
wise, miR-200b-3p and quercetin tumorspheres had signifi-
cantly lower cell numbers than the tumorspheres from the
control groups (Fig. 5b). This therefore indicates that miR-
200b-3p inhibits proliferation and it is consistent with the
inhibition of self-renewal and hints of likely differentiation.
MiR-200b-3p triggers cell differentiation by inhibiting
notch signaling
To substantiate the likelihood of differentiation, we cul-
tured the dissociated tumorsphere cells in regular medium
(DMEM, 10% FCS, 1% HEPES). The cells were left
untransfected or treated with 50 μM quercetin or 50nM
mirVana™ mimics of miR-200b-3p or a miR-NC for every
72 h for a period of 12 days and subsequently evaluated
for osteogenic, adipogenic and chrongenic differentiations.
High heterogeneous expressions of osteoblasts, adipocytes
and chondrocytes were detected in the miR-200b-3p and
quercetin treated groups while little or no differentiation
activity was detected in the control groups (Fig. 6a, b
and c). These observations suggest that the differenti-
ation is as a result of the inhibition of self-renewal
(Additional file 4: Figure S2).
Discussion
In this study, we show that highly aggressive PDA cells
with CSC features can perform self-renewal by symmetric
division; yielding two CSCs. In addition, the cells can div-
ide asymmetrically; yielding a CSC and a differentiated
non-CSC. However, the symmetric division mode was
more prevalent. MiR-200b-3p plays a major role in the
Fig. 5 MiR-200b-3p inhibits cell proliferation. a The number of tumorspheres from each generation was counted under a light microscope.
b Trypsin-EDTA was used to dissociate the tumorspheres to single cells. The viable cells were counted using the automated Z™ Series
COULTER COUNTER® Cell and Particle Counter. All assays were performed in triplicates, repeated at least three times and the mean ± S.D.
are shown. *P < 0.05, **P < 0.01
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decision of a PDA cell to perform either symmetric or
asymmetric division by modulating Notch signaling. And it
putatively targets the segregating determinants. Hence, miR-
200b-3p is suggested as a cell determinant miR in PDA.
Quercetin has been shown to inhibit pancreatic can-
cer growth and self-renewal [36, 37]. In our previous
study, we demonstrated that miRs are robust alterna-
tives to facilitate the delivery of quercetin mediated ef-
fects to patients, which otherwise is very challenging to
be achieved by diet alone [24]. The miR-200 family of
microRNAs made up of five members (miR-200a, miR-
200b, miR-200c, miR-141 and miR-429) is an enforcer
of the epithelial phenotype [38]. They are crucial
players in cancer initiation, proliferation, migration, in-
vasion and tumor growth [39]. MiR-200b in particular
has been found to be involved in tumorigenesis and in-
hibition of tumor growth and cell fate control [40, 41].
Herein, we have shown that the expression of miR-
200b is modulated by quercetin. Its expression is low in
PDA cells and induced to higher levels upon quercetin
treatment. This is the first time these findings have ever
been identified. However, they are not surprising, owing
to the fact that miR-200b is expressed at high levels in
normal epithelial cells like the pancreas [42]. Thus, quer-
cetin induces miR-200b expression in PDA cells in a bid
to return it back to normalcy.
Symmetric division was observed to be more preva-
lent in PDA cells and patient derived tissues. Remark-
ably, in the patient derived tissues, the symmetrically
dividing cells were mainly observed in the pancreatic
duct glands. The pancreatic ducts are known to pos-
sess stem cell niches and are the principal site of pro-
liferation [43]. Symmetric division inevitably causes
exponential cell division leading to tumor growth and
progression.
An important factor in tumor growth and cell fate de-
termination is the Notch signaling. Symmetric division
gives rise to two identical cells in which the Notch sig-
naling pathway is active in both of them. On the other
hand, asymmetric gives rise to one cell in which the
Notch signaling pathway becomes activated and one in
which this pathway remains inactive. Notch acts by its
ligand binding to its receptors causing the cleavage of
Notch receptors and the resulting nuclear translocation
of Notch intracellular domain (NICD) [44]. The differ-
ence in Notch signaling activity is established by Numb.
Its functional role on cell fate decisions is exercised by
antagonizing Notch signaling activities. This it does by
the ubiquitination of the membrane bound Notch1 re-
ceptor consequently degrading its NICD upon receptor
activation [17]. Our results show that the significantly
higher expression of Notch compared to Numb, which
occurred in PDA cells, is reversed by miR-200b-3p or
quercetin. This observation, which suggests a switch
Fig. 6 MiR-200b-3p triggers cell differentiation. a Dissociated AsPC1,
AsanPaca and PANC1 cells were cultured in regular medium (DMEM,
10% FCS, 1% HEPES). The cells were treated with 50 nM of miR-
200b-3p or miR control (miR-NC) mimics for 72 h or were treated
with quercetin 50 μM for 12 h (Q) or were left untreated (CO) for
every 72 h for a period of 12 days and subsequently evaluated for
osteogenic differentiation. Heterogeneous osteogenic differentiation
was detected using Sigma Fast BCIP/NBT substrate. The positive cells
appear deep bluish purple. b Dissociated AsPC1, AsanPaca and
PANC1 cells were treated as described above and evaluated for
adipogenic differentiation. Heterogeneous adipocytes were stained
red by the Oil Red O staining solution and visualized with a 10 ×
magnification using an inverted microscope c Dissociated AsPC1,
AsanPaca and PANC1 cells were treated as described above and
evaluated for chrondrogenic differentiation. Heterogeneous
chondrogenic differentiation was detected as intense dark-blue
coloration while the other cells were mostly light bluish. The bar
indicates 100 μm
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from symmetric to asymmetric division, was further
strengthened by our time-lapse microscopy analysis.
Apart from Numb, there are other proteins that are in-
volved in cell fate determination like Prox1 and Trim.
Together with Numb, they are known as human segre-
gating determinants because their segregation into one
of the two daughter cells results to distinct cell fates
[45]. Our in silico analyses have shown that miR-200b
putatively targets the segregating determinants. In line
with our observations are studies that identified Trim as
a regulator of asymmetric division, cellular differenti-
ation and Notch signaling in CSCs [34]. Herein, they
were critical in the decision to select miR-200b-3p as
the most important miR candidate out the 11 miRs in-
volved in Notch signaling.
To further understand the mechanism of the
quercetin-induced miR-200b-3p regulation of the mode
of self-renewal divisions, tumorspheres propagation
assay was performed. Noteworthy inhibition of self-
renewal by miR-200b-3p or quercetin was observed
with concomitant decrease in proliferation. Further ana-
lyses of the resulting cells from the tumorspheres indi-
cated immense differentiation of the cells by miR-200b-3p
or quercetin. These results correspond to observations
that elevated Numb levels support differentiation [46].
Conclusion
Taken together, we conclude that miR-200b-3p is down-
regulated in PDA and its induction by quercetin may
render the CSCs less aggressive by a switch of the cell
division mode. MiR-200b-3p influences cell fate decisions
in PDA by modulating Notch signaling. By reversing the
elevated Notch levels with simultaneous decrease in
Numb levels, inhibition of self-renewal and decrease of
proliferation, it switches symmetric to asymmetric div-
ision. Hence, we propose miR-200b-3p as a cell fate deter-
minant in PDA. Restoration of miR-200b-3p functions in
cancer cells may represent an important therapeutic strat-
egy for future cancer treatment.
Additional files
Additional file 1: Figure S1. Double immunofluorescence staining was
performed on 6-μm frozen pancreatic ductal adenocarcinoma patient
tissue sections using mouse monoclonal anti-Cytokeratin, pan (Mixture)
antibody (Sigma-Aldrich, USA), rabbit monoclonal anti-Notch1 antibody
(Cell Signaling, Danvers, MA), goat polyclonal Numb antibody (Abcam,
Cambridge, UK) and rabbit polyclonal Ki67 antibody (Abcam, Cambridge,
UK). (PDF 15592 kb)
Additional file 2: Movie S1. A single AsPC1 cell was monitored over
three replication cycles under physiologic conditions for about 80 h
using time-lapse microscopy. The cells were re-focused periodically to
avoid out-of-focus images. The images were processed using FIJI soft-
ware. (MP4 1559 kb)
Additional file 3: Data 1 The binding sites of miR-200b-3p in the 3’UTR
of Numb, Prox1, Trim2 and Notch1 were identified using TargetScan
database. (XLSX 247 kb)
Additional file 4: Conditioned experiement was performed to confirm
whether the effects of quercetin are due to the upregulation of miR-
200b-3p, using eight conditions as follows: (1) Control, untreated cells
(CO), (2) MiRNA negative control (miR-NC), (3) MiR-200b-3p inhibitor
(miR-200b-), (4) MiR-200b-3p mimic (miR-200b+), (5) Quercetin (Q), (6)
Quercetin plus miRNA negative control (Q+miR-NC), (7) Quercetin plus
miR-200b-3p inhibitor (Q+miR-200b-), (8) Quercetin plus miR-200b-3p
mimic (Q+miR-200b+). Pancreatic cancer cell line AsPC1 in the aforemen-
tioned treatment groups were evaluated for tumorsphere formation. The
resulting tumorspheres were evaluated and thereafter dissociated into
single cells and the cell numbers evaluated. The resulting cells were
plated with DMEM + FCS + HEPES. After 72h of treatment as listed above,
the cells were evaluated for osteogenic and chondrogenic differentiation.
(PDF 188 kb)
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